GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » T2 Biosystems Inc (FRA:3T2) » Definitions » Float Percentage Of Total Shares Outstanding

T2 Biosystems (FRA:3T2) Float Percentage Of Total Shares Outstanding : 95.13% (As of Jun. 09, 2024)


View and export this data going back to 2014. Start your Free Trial

What is T2 Biosystems Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, T2 Biosystems's float shares is 16.24 Mil. T2 Biosystems's total shares outstanding is 17.07 Mil. T2 Biosystems's float percentage of total shares outstanding is 95.13%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, T2 Biosystems's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, T2 Biosystems's Institutional Ownership is 0.31%.

T2 Biosystems Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

T2 Biosystems's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=16.24/17.07
=95.13%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

T2 Biosystems (FRA:3T2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » T2 Biosystems Inc (FRA:3T2) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
TRIB OCX CHEK PMD STRR BIAF PRPO APDN XGN LMDX TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
TTOO:USA
Address
101 Hartwell Avenue, Lexington, MA, USA, 02421
Website
https://www.t2biosystems.com
T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.

T2 Biosystems (FRA:3T2) Headlines

No Headlines